Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of first Clostridium difficile infection episodes with bacteriotherapy versus vancomycin
2017-003147-38Phase 4Active
- Sponsor
- Emilio Bouza Santiago
- Start
- Oct 2017
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in Clostridioides difficile colitis (CDI), sponsored by Emilio Bouza Santiago. Started Oct 2017; status: active.
02
Drugs
vancomycin
03
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on 2017-003147-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003147-38.